Serum Institute of India reduces ‘Covishield’ vaccination price to the States by 25%
Serum Institute of India in its latest statement announced that it was decreasing the cost of its Covishield vaccine to INR 300 per dose. For the record, the vaccine was earlier available to the states at INR 400 per dose. Adar Poonawalla, CEO, SII quoted the move as a philanthropic gesture that will help save the states thousands of crores of funds and will enhance accessibility to the vaccine saving innumerable lives. Serum Institute of India received huge flak last week for the alleged high pricing for its vaccine. The world’s largest vaccine manufacturer responded to the criticism by citing the comparisons between global and country level pricing inaccurate. SII in its explanation cited that the initial global pricing of the vaccine was low as it was based on advanced funding by the countries for at-risk vaccine manufacturing. The pharmaceutical giant also maintained that the initial supply cost of Covishield has been the lowest for all government vaccination programme, includi...